These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 1655614)

  • 1. Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease.
    Chittal SM; Brousset P; Voigt JJ; Delsol G
    Histopathology; 1991 Sep; 19(3):211-20. PubMed ID: 1655614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease.
    McBride JA; Rodriguez J; Luthra R; Ordóñez NG; Cabanillas F; Pugh WC
    Am J Surg Pathol; 1996 Feb; 20(2):193-201. PubMed ID: 8554109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells.
    Lim MS; Beaty M; Sorbara L; Cheng RZ; Pittaluga S; Raffeld M; Jaffe ES
    Am J Surg Pathol; 2002 Nov; 26(11):1458-66. PubMed ID: 12409722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
    Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
    Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
    Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
    Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.
    Chittal SM; Caverivière P; Schwarting R; Gerdes J; Al Saati T; Rigal-Huguet F; Stein H; Delsol G
    Am J Surg Pathol; 1988 Jan; 12(1):9-21. PubMed ID: 2827535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Morphoimmunohistological differential diagnosis between Hodgkin's lymphoma with lymphoid prevalence and large B-cell lymphoma].
    Kovrigina AM; Probatova NA
    Arkh Patol; 2005; 67(4):10-6. PubMed ID: 16209291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell rich B-cell lymphoma--a case report.
    Pai RR; Khadilkar UN; Pai MR; Dinesh M
    Indian J Pathol Microbiol; 2003 Jul; 46(3):427-8. PubMed ID: 15025291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell rich b-cell non-hodgkin's lymphoma: a progressed form of follicle centre cell lymphoma and lymphocyte predominance hodgkin's disease.
    De Jong D; Van Gorp J; Sie-Go D; Van Heerde P
    Histopathology; 1996 Jan; 28(1):15-24. PubMed ID: 8838116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin's disease from nodular sclerosing Hodgkin's disease, T-cell-rich B-cell lymphoma and follicular lymphoma.
    Kamel OW; Gelb AB; Shibuya RB; Warnke RA
    Am J Pathol; 1993 Feb; 142(2):541-6. PubMed ID: 7679553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell-rich B-cell lymphomas. A clinicopathologic study of 19 cases.
    Macon WR; Williams ME; Greer JP; Stein RS; Collins RD; Cousar JB
    Am J Surg Pathol; 1992 Apr; 16(4):351-63. PubMed ID: 1373580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
    Peh SC; Kim LH; Poppema S
    Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histopathological diagnosis of Hodgkin's disease].
    Delsol G
    Rev Prat; 1998 May; 48(10):1060-4. PubMed ID: 9781148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma).
    Rüdiger T; Jaffe ES; Delsol G; deWolf-Peeters C; Gascoyne RD; Georgii A; Harris NL; Kadin ME; MacLennan KA; Poppema S; Stein H; Weiss LE; Müller-Hermelink HK
    Ann Oncol; 1998; 9 Suppl 5():S31-8. PubMed ID: 9926235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The malignant lymphomas of Kenya: morphology, immunophenotype, and frequency of Epstein-Barr virus in 73 cases.
    Cool CD; Bitter MA
    Hum Pathol; 1997 Sep; 28(9):1026-33. PubMed ID: 9308726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin's and non-Hodgkin's lymphoma: spectrum of morphologic and immunophenotypic overlap.
    Elgin J; Phillips JG; Reddy VV; Gibbs PO; Listinsky CM
    Ann Diagn Pathol; 1999 Oct; 3(5):263-75. PubMed ID: 10556472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of immunoglobulin light chain mRNA in nodular sclerosing Hodgkin's disease by in situ hybridization with biotinylated oligonucleotide probes compared with immunohistochemical staining with poly- and monoclonal antibodies.
    Lauritzen AF; Pluzek KJ; Kristensen LE; Nielsen HW
    Histopathology; 1992 Oct; 21(4):353-8. PubMed ID: 1398538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypic study of lymphocyte predominance Hodgkin's disease.
    Bishop PW; Harris M; Smith AP; Elsam KJ
    Histopathology; 1991 Jan; 18(1):19-24. PubMed ID: 2013458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma.
    Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF
    Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte predominance Hodgkin's disease--an immunohistochemical study.
    Nicholas DS; Harris S; Wright DH
    Histopathology; 1990 Feb; 16(2):157-65. PubMed ID: 2323737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.